Cardinal Health 2011 Annual Report Download - page 45

I
tem
6
:
S
e
l
ecte
d
Financia
l
Data
T
he consolidated financial data include all business combinations as of the date of ac
q
uisition that occurre
d
d
ur
i
ng t
h
ese per
i
o
d
s. T
h
e
f
o
ll
ow
i
ng se
l
ecte
d
conso
lid
ate
dfi
nanc
i
a
ld
ata s
h
ou
ld b
e rea
di
n con
j
unct
i
on w
i
t
h
t
he
C
ompan
y
’s consolidated financial statements and related notes and “Item 7—Mana
g
ement’s Discussion an
d
Analysis of Financial Condition and Results of Operations.
”
At or for the Fiscal Year Ended June 30
,
2
0
1
1
20
1
0
2
009
2008
2
00
7
(
In millions, exce
p
t
p
er common share amounts
)
Earn
i
n
g
s Data
:
R
e
v
enu
e
.................................
$
102,644.2 $98,502.8 $95,991.5 $87,408.2 $84,220.4
Earnin
g
s from continuin
g
operations
..........
966.2
5
87.0 7
5
8.2 847.2
5
32.1
Earn
i
ngs
f
rom
di
scont
i
nue
d
operat
i
ons (1
)
.....
.
(
7.2
)
55.2 393.4 453.4 1,399.0
Net earnings
.
.............................
$
959.0
$
642.2
$
1,151.6
$
1,300.6
$
1,931.1
B
as
i
c earn
i
ngs per Common S
h
ar
e
Continuin
g
operations
.
................. $ 2.77 $ 1.64 $ 2.12 $ 2.37 $ 1.3
5
D
iscontinued o
p
erations (1
)
............
.
(
0.02
)
0.1
5
1.10 1.26 3.
54
Net basic earnin
g
s per Common Shar
e
.
........ $ 2.75 $ 1.79 $ 3.22 $ 3.63 $ 4.89
D
il
ute
d
earn
i
ngs per Common S
h
are
Cont
i
nu
i
n
g
operat
i
ons
.
.................
$
2.74
$
1.62
$
2.10
$
2.33
$
1.31
D
iscontinued o
p
erations (1
)
.............
(
0.02) 0.1
5
1.08 1.24 3.46
Net
dil
ute
d
earn
i
n
g
s per Common S
h
are
.
...... $ 2.72 $ 1.77 $ 3.18 $ 3.57 $ 4.77
C
ash dividends declared
p
er Common Share
....
0
.800 0.720 0.
5
9
5
0.
5
00 0.390
Balance
S
heet Data:
T
ota
l
asset
s
.
............................. $
2
2,845.9 $19,990.2 $25,118.8 $23,448.2 $23,153.
8
Lon
g
-term obli
g
ations, less current portion and
o
t
h
er s
h
ort-term
b
orrow
i
ng
s
..............
.
2
,
175.3 1
,
896.1 3
,
271.6 3
,
681.7 3
,
447.3
S
h
are
h
o
ld
ers’ equ
i
t
y
(2) (3)
.................
5,848.6 5,276.1 8,724.7 7,747.5 7,376.9
(1) On Au
g
ust 31, 2009, we separated the clinical and medical products businesses from our other businesses
t
h
roug
h
a pro rata
di
str
ib
ut
i
on to s
h
are
h
o
ld
ers o
f
81 percent o
f
t
h
et
h
en outstan
di
ng common stoc
k
o
f
CareFus
i
on an
d
met t
h
ecr
i
ter
i
a
f
or c
l
ass
ifi
cat
i
on o
f
t
h
ese
b
us
i
nesses as
di
scont
i
nue
d
operat
i
ons. Dur
i
n
g
t
he
fourth quarter of fiscal 2009, we committed to plans to sell our United Kin
g
dom-based Martindale in
j
ectable
m
anu
f
actur
i
ng
b
us
i
ness w
i
t
hi
n our P
h
armaceut
i
ca
l
segment, an
d
met t
h
ecr
i
ter
i
a
f
or c
l
ass
ifi
cat
i
on o
f
t
hi
s
b
us
i
ness as
di
scont
i
nue
d
operat
i
ons. Dur
i
ng t
h
e secon
d
quarter o
ffi
sca
l
2007, we comm
i
tte
d
to p
l
ans to se
ll
our former Pharmaceutical Technolo
g
ies and Services se
g
ment, other than certain
g
eneric-focused
b
us
i
nesses, an
d
met t
h
ecr
i
ter
i
a
f
or c
l
ass
ifi
cat
i
on as
di
scont
i
nue
d
operat
i
ons. For a
ddi
t
i
ona
li
n
f
ormat
i
o
n
regarding discontinued operations, see Note 5 of the “Notes to Consolidated Financial Statements.”
(2) In the first quarter of fiscal 2008, we adopted new accountin
gg
uidance re
g
ardin
g
the accountin
g
fo
r
u
ncerta
i
nty
i
n
i
ncome taxes recogn
i
ze
di
nt
h
e
fi
nanc
i
a
l
statements. T
hi
s account
i
ng gu
id
ance prov
id
es t
h
at a
tax
b
ene
fi
t
f
rom an uncerta
i
n tax pos
i
t
i
on may
b
e recogn
i
ze
d
w
h
en
i
t
i
s more
lik
e
l
yt
h
an not t
h
at t
he
position will be sustained upon examination, includin
g
resolutions of an
y
related appeals or liti
g
atio
n
processes,
b
ase
d
on t
h
e tec
h
n
i
ca
l
mer
i
ts. T
h
e amount recogn
i
ze
di
s measure
d
as t
h
e
l
argest amount o
f
tax
benefit that is
g
reater than 50 percent likel
y
of bein
g
realized upon settlement. The cumulative effect o
f
adoptin
g
this accountin
gg
uidance was a $139 million reduction of retained earnin
g
s.
(3) As note
d
a
b
ove, on August 31, 2009, we comp
l
ete
d
t
h
e
di
str
ib
ut
i
on to our s
h
are
h
o
ld
ers o
f
81 percent o
f
t
he
t
h
en outstan
di
n
g
common stoc
k
o
f
CareFus
i
on an
d
reta
i
ne
d
t
h
e rema
i
n
i
n
g
41.4 m
illi
on s
h
ares o
f
CareFus
i
on
c
ommon stock. The distribution of CareFusion common stock to our shareholders resulted in the reco
g
nition
of a
$
3.7 billion non-cash dividend
.
19